Laura Kim
laura3216.bsky.social
Oncology biopharma professional with 12+ years in cancer research, clinical development and innovative treatment strategies.
👤 Joined on 02 September 2024
26
Followers
14
Following
4
Total Posts
📜 Kullanıcı Geçmişi
- 02 Eyl 2024, 17:59
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@igaosouza.bsky.social - 24 Ağu 2025, 18:03
✏️ Kullanıcı adı değişti:
@igaosouza.bsky.social→@laura3216.bsky.social
🚫 Blokladığı Kullanıcılar
Bu kullanıcının blokladığı kullanıcı bulunamadı.
❤️ Beğendiği Gönderiler
Over the past 20 years, CD40 agonist antibodies showed promise in activating the immune system against cancer, but in clinical trials, they had limited effectiveness and caused serious side effects like inflammation, low platelets, and liver toxicity.
Show Post
#Vivus’ John Amos on AI, the #FDA and what it’s like to work with the agency. #Biopharma #Pharmaceuticals #Biotechnology #DrugDevelopment #Therapeutics #ObesityTreatment #CardiometabolicHealth #PharmaNews #BiotechInvesting #Biotech
Show Post